Patent · US Active

Using impedance-based cell response profiling to identify putative inhibitors for oncogene addicted targets or pathways

US10620188B2 · kind B2 · utility

0Cited by
97References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 2, 2017
Grant dateApr 14, 2020
Priority date
Expiry dateNov 11, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/4716
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Methods of identifying whether a biologically active agent affects an oncogene addicted pathway within a cancer cell, by introducing a biologically active agent suspected of affecting an oncogene addicted pathway to a first well and a negative control to a second well, and introducing a stimulating agent that stimulates the oncogene addicted pathway to both wells; monitoring cell-substrate impedance of the two wells and optionally determining cell indices from impedance values; generating an impedance based curve for each of the two wells from the impedance values or from the cell indices; comparing the impedance-based curves to determine a degree of similarity; and if significantly different concluding the biologically active agent affects the oncogene addicted pathway within the cancer cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.